Most men with an enlarged prostate begin their treatment journey with medications. And for many — particularly those with mild to moderate symptoms — tablets work well enough to restore a reasonable quality of life. But medications for BPH have important limitations that every patient deserves to understand clearly. They control symptoms while the prostate continues to grow underneath. They require daily commitment, indefinitely. And for a significant proportion of men, they eventually stop providing adequate relief.
The question every man with BPH eventually faces is not whether surgery is an option — it is whether surgery is the right option for him, right now. This blog explores exactly that decision: what medications can and cannot do, what modern BPH surgery involves, and how to know when the time has come to move from tablets to the operating theatre.
A Quick Recap: What BPH Does to Your Body
Benign Prostatic Hyperplasia is the non-cancerous enlargement of the prostate gland that affects the majority of men from their 50s onwards. As the prostate grows, it squeezes the urethra running through its centre — creating resistance to urine flow and forcing the bladder to work harder. Over time, the bladder muscle itself changes — thickening, becoming irritable, and eventually losing its ability to empty efficiently.
The symptoms this causes fall into two groups: obstructive symptoms — weak stream, hesitancy, straining, incomplete emptying — and irritative symptoms — urgency, frequency, nocturia. When both are present significantly, quality of life suffers markedly. Sleep is disrupted. Social activities are planned around toilet access. The condition that began as a mild inconvenience gradually becomes a daily burden.
What Medications Actually Do
There are two main classes of BPH medications, and understanding what each does — and does not do — is essential for making an informed decision:
Alpha-Blockers (Tamsulosin, Alfuzosin, Silodosin)
These relax the smooth muscle of the prostate and bladder neck — reducing resistance to urine flow without actually shrinking the prostate. They work relatively quickly, often within days to weeks. They are good for symptom relief but do not change the natural history of BPH — the prostate continues to grow, and long-term, symptoms can break through. Common side effects include dizziness, retrograde ejaculation, and postural hypotension.
5-Alpha Reductase Inhibitors (Finasteride, Dutasteride)
These block the conversion of testosterone to dihydrotestosterone (DHT) — the primary hormonal driver of prostate growth. Over 6-12 months, they shrink the prostate by 20-30% and reduce the long-term risk of urinary retention and the need for surgery. However, they require 6+ months before significant benefit is felt, cause sexual side effects in a proportion of men, and are most beneficial in men with larger prostates. Importantly, they lower PSA levels by approximately 50% — which must be factored into prostate cancer screening interpretation.
When Medications Are No Longer Enough
There are clear clinical situations where continuing with medication is not the right answer — and where surgery offers superior, more durable outcomes:
- Acute urinary retention: A sudden, complete inability to urinate requiring emergency catheterisation. After a first episode of retention, the risk of recurrence is high and surgery is generally recommended.
- Recurrent urinary tract infections: Caused by incomplete bladder emptying creating a reservoir for bacterial growth. Antibiotics treat the infection — surgery addresses the cause.
- Bladder stones: Formed from concentrated stagnant urine in the bladder due to chronic obstruction. Require surgical removal — and the underlying BPH should be addressed simultaneously.
- Renal impairment from obstructive uropathy: When long-standing BPH obstruction has begun to affect kidney function — surgery is urgent.
- Significant post-void residual: Large volumes of urine remaining in the bladder after voiding despite medication, indicating the bladder muscle is beginning to fail.
- Inadequate symptom control despite optimal medical therapy: When a man continues to have significantly impaired quality of life despite adequate trials of alpha-blocker and 5-ARI combination therapy.
- Patient preference: A man who understands his options and prefers a definitive surgical solution over lifelong medication is making a valid, supported choice.
Modern BPH Surgery: What Are the Options?
Bipolar TURP — The Gold Standard
Transurethral Resection of the Prostate using bipolar energy technology remains the most widely validated and effective surgical treatment for BPH in the 30-80mL prostate size range. Performed entirely through the urethra — no external incisions — the obstructing prostate tissue is resected using an electrosurgical loop. Modern bipolar technology eliminates the risk of TURP Syndrome that affected older monopolar techniques, significantly reduces blood loss, and shortens recovery. Most patients experience dramatic symptom improvement within weeks, with results lasting 10-15 years.
Holmium Laser Enucleation of the Prostate (HoLEP)
The preferred technique for very large prostates (over 80-100mL) where TURP alone would be insufficient. The entire obstructing prostate adenoma is enucleated (removed whole) using a Holmium laser passed through the urethra, then morcellated into fragments within the bladder. HoLEP is size-independent — even very large prostates can be treated safely. It has the lowest retreatment rates of any BPH surgical technique and is particularly valuable in patients on anticoagulants due to superior haemostasis.
GreenLight Laser Vaporisation (PVP)
Uses a high-powered green wavelength laser to vaporise obstructing prostate tissue. Offers minimal bleeding and is particularly suitable for men on blood thinning medications. Effective for moderate-sized prostates with good symptom relief, though retreatment rates are slightly higher than TURP or HoLEP at 10 years.
UroLift
A truly minimally invasive option that places small implants to mechanically hold the enlarged prostate lobes apart without removing tissue. No heat, no cutting, no retrograde ejaculation risk. Ideal for men with smaller to moderate prostates who wish to preserve ejaculatory function. Not suitable for all BPH anatomies and has lower long-term durability than resection techniques — but for the right patient, it is an elegant solution.
Making the Decision Together
The decision between continuing medication and proceeding to surgery should never be made unilaterally by a doctor. It is a shared decision — informed by the severity of symptoms, prostate size, presence of complications, patient health, and what the patient himself values most. Some men prioritise avoiding surgery at all costs. Others reach a point where they want the problem definitively solved and are tired of daily tablets and ongoing inconvenience.
Both positions are valid. What matters is that the decision is made with complete, accurate information — and guidance from an experienced urologist who presents all options honestly. For expert BPH Treatment in Ahmedabad — including the full range of modern surgical techniques — Dr. Prarthan Joshi at Zydus Hospitals offers exactly that. One consultation can give you the clarity you need to make the right choice for your life.